March 1, 2022
The European Medicines Agency’s (EMA’s) human medicines committee has recommended approval of a hepatitis B vaccine for adults. The agency’s Committee for Medicinal Products for Human […]
March 1, 2022
Patients who have undergone endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) need lifelong surveillance, including imaging, the US Food and Drug Administration (FDA) advises. […]
March 1, 2022
A new treatment option for patients with refractory/relapsed multiple myeloma who have already tried four or more therapies has been approved by the US Food and […]
February 24, 2022
The US Food and Drug Administration (FDA) has approved an expanded heart failure (HF) indication for the SGLT2 inhibitor empagliflozin (Jardiance) that now includes HF with […]
February 24, 2022
The US Food and Drug Administration (FDA), on February 23, finalized its decision approving the therapeutic equivalence of a generic formulation of the SGLT2 inhibitor dapagliflozin […]
February 17, 2022
The recommended vaccination schedule for people in the United States aged 19 years and older has been released by the Advisory Committee on Immunization Practices (ACIP) […]
February 9, 2022
Enteral feeding kits pose a risk for strangulation in children, according to a safety alert from the US Food and Drug Administration (FDA). The safety alert […]
February 7, 2022
A new drug has become the first and only treatment for people with cold agglutinin disease (CAD) that is approved by the US Food and Drug […]
February 1, 2022
A new cell therapy will be available in Europe soon for the treatment of certain blood cancers. At its late January meeting, the Committee for Medicinal Products […]